SAN DIEGO, March 16, 2022 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) has invested in seven new genomics companies to join the fourth global funding cycle of Illumina Accelerator San Francisco Bay Area and Cambridge, UK. The global company creation engine is focused on partnering with entrepreneurs to build breakthrough genomics startups and its next global funding cycle application deadline is April 1, 2022.
Illumina Accelerator is accepting applications this month for its next global cohort of genomics startups, the deadline is April 1.